We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




EMR-Based Tool Predicts Graft Failure After Kidney Transplant

By HospiMedica International staff writers
Posted on 12 Dec 2025

Kidney transplantation offers patients with end-stage kidney disease longer survival and better quality of life than dialysis, yet graft failure remains a major challenge. More...

Although a successful transplant is expected to last about a decade, nearly one in four kidney grafts fail within five years, often without early warning signs. Clinicians currently lack reliable ways to identify which patients are most at risk of losing a transplanted kidney. A new study now shows that routinely collected kidney function data can be used to dynamically predict graft failure risk years before it happens.

Researchers at Johns Hopkins Medicine (Baltimore, MD, USA) have developed an electronic medical record (EMR)–based prediction model that continuously updates a patient’s risk of graft failure using changes in estimated glomerular filtration rate, a standard blood test that reflects how well a transplanted kidney is functioning. The approach allows risk to be recalculated every time new lab results become available.

The model was built using data from 1,114 deceased-donor kidney transplant recipients and validated across multiple large datasets, including national transplant registries and real-world hospital records. Investigators analyzed repeated kidney function measurements over time and linked these trajectories to graft failure, defined as a return to dialysis or the need for a second transplant within three years.

The results, published in the Clinical Journal of the American Society of Nephrology, showed that the model could effectively distinguish high-risk from low-risk patients. Predictive accuracy reached 0.70 just three months after transplant and improved to 0.90 by 30 months, demonstrating strong performance well before clinical failure occurred.

By identifying patients at elevated risk, the tool could support earlier interventions such as closer monitoring, adjustments to immunosuppressive therapy, and counseling about future transplant needs. At the same time, patients at low risk could safely transition back to routine nephrology care closer to home, freeing transplant center resources.

Researchers now plan to test the model in everyday clinical practice and expand it by incorporating additional health data, including clinical events and other laboratory markers. These efforts aim to further improve early detection of graft injury and long-term transplant outcomes.

“The results from this study can be readily implemented at transplant centers to streamline care of kidney transplant recipients by providing updated risk predictions as new data become available,” said Chirag Parikh, MD, PhD, the study’s senior author. “There could also be future downstream models developed to predict other infections and immunologic complications.”

Related Links:
Johns Hopkins Medicine


Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Hemostatic Agent
HEMOBLAST Bellows
Mammo DR Retrofit Solution
DR Retrofit Mammography
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: The collaboration will integrate Masimo’s innovations into Philips’ multi-parameter monitoring platforms (Photo courtesy of Royal Philips)

Philips and Masimo Partner to Advance Patient Monitoring Measurement Technologies

Royal Philips (Amsterdam, Netherlands) and Masimo (Irvine, California, USA) have renewed their multi-year strategic collaboration, combining Philips’ expertise in patient monitoring with Masimo’s noninvasive... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.